Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Free Cash Flow (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Free Cash Flow for 5 consecutive years, with -$12.0 million as the latest value for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 28.95% year-over-year to -$12.0 million; the TTM value through Dec 2025 reached -$51.8 million, up 30.25%, while the annual FY2025 figure was -$51.8 million, 30.25% up from the prior year.
  • Free Cash Flow hit -$12.0 million in Q4 2025 for Kezar Life Sciences, down from -$9.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$8.4 million in Q1 2021 and bottomed at -$22.9 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$15.6 million, with a median of -$15.9 million recorded in 2022.
  • Year-over-year, Free Cash Flow plummeted 64.7% in 2022 and then soared 43.87% in 2025.
  • Kezar Life Sciences' Free Cash Flow stood at -$11.5 million in 2021, then plummeted by 38.14% to -$15.8 million in 2022, then dropped by 19.76% to -$19.0 million in 2023, then grew by 11.3% to -$16.8 million in 2024, then grew by 28.95% to -$12.0 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$12.0 million, -$9.8 million, and -$12.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.